Jasper Therapeutics Reports Key Corporate Events
Ticker: JSPRW · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change, restructuring
Related Tickers: JSPR
TL;DR
Jasper Therapeutics is shuffling execs and directors, filing 8-K on July 8th.
AI Summary
Jasper Therapeutics, Inc. filed an 8-K on July 9, 2025, reporting on several key events as of July 8, 2025. These include cost associated with exit or disposal activities, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. The filing also covers other events and financial statements/exhibits.
Why It Matters
This filing indicates significant changes in the company's leadership and operational structure, which could impact its strategic direction and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with exit/disposal activities, can signal underlying business challenges or strategic shifts that carry inherent risk.
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- July 8, 2025 (date) — Earliest event reported
- July 9, 2025 (date) — Filing date
FAQ
What specific cost is associated with the exit or disposal activities mentioned in the filing?
The filing mentions 'Cost Associated with Exit or Disposal Activities' as an item, but does not specify the dollar amount or nature of these costs in the provided text.
Who are the directors or officers that have departed from Jasper Therapeutics?
The filing lists 'Departure of Directors or Certain Officers' as an item, but does not name the individuals involved in the provided text.
Were there any new directors elected or officers appointed?
Yes, the filing indicates 'Election of Directors' and 'Appointment of Certain Officers' as reported events.
What are the details of the compensatory arrangements for certain officers?
The filing notes 'Compensatory Arrangements of Certain Officers' as a reported item, but specific details are not included in the provided text.
What is the SIC code for Jasper Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Jasper Therapeutics, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).